You have accessJournal of UrologyCME1 May 2022MP35-16 IMPROVING QUALITY OF LIFE FOR PATIENTS WITH CHRONIC PELVIC AND GENITAL PAIN THROUGH AN INTERDISCIPLINARY PAIN REHABILITATION PROGRAM Kevin Hanna, Matthew Ziegelmann, Hannah Betcher, Sevann Helo, Elizabeth Kacel, and Wesley Gilliam Kevin HannaKevin Hanna More articles by this author , Matthew ZiegelmannMatthew Ziegelmann More articles by this author , Hannah BetcherHannah Betcher More articles by this author , Sevann HeloSevann Helo More articles by this author , Elizabeth KacelElizabeth Kacel More articles by this author , and Wesley GilliamWesley Gilliam More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002589.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Chronic pelvic and/or genital pain is a disabling condition and commonly associated with poor quality of life, impaired sexual function, and decreased productivity. METHODS: A series of within-subject ANOVAs (corrected for multiple comparisons) were used to evaluate the effectiveness of an Interdisciplinary Pain Rehabilitation Program (IPRP) on self-reported (pain severity, interference, depressive symptoms, quality of life) and observer-rated outcomes (5-minute walk) among 15 patients receiving care at the Mayo Clinic IPRP between 2016–2018. Additionally, opioid use of participants was assessed throughout the program via total daily Morphine Milligram Equivalents (MME). RESULTS: Fifteen patients (5 male, 10 female) were identified. Mean age was 47.0 (range: 24–78) and primary diagnoses were pelvic pain (n=13) and penile pain (n=2). Significant within-subject effects were detected for all self-report outcomes and the 5-minute walk test (Table 1). Six patients were on opioid therapy (MME = 49 mg), and all but one successfully tapered off opioids. In the remaining patient, daily MME decreased from 150 mg to 30 mg (Figure 1). CONCLUSIONS: Intensive outpatient IPRP significantly improves quality of life for patients with treatment-refractory chronic pelvic and/or genital pain. These results support multi-disciplinary treatment paradigms for refractory urogenital pain. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e593 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Kevin Hanna More articles by this author Matthew Ziegelmann More articles by this author Hannah Betcher More articles by this author Sevann Helo More articles by this author Elizabeth Kacel More articles by this author Wesley Gilliam More articles by this author Expand All Advertisement PDF DownloadLoading ...
Read full abstract